These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37080831)

  • 1. Modelling the relative cost-effectiveness of the RTS,S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis.
    Topazian HM; Schmit N; Gerard-Ursin I; Charles GD; Thompson H; Ghani AC; Winskill P
    Vaccine; 2023 May; 41(20):3215-3223. PubMed ID: 37080831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.
    Penny MA; Verity R; Bever CA; Sauboin C; Galactionova K; Flasche S; White MT; Wenger EA; Van de Velde N; Pemberton-Ross P; Griffin JT; Smith TA; Eckhoff PA; Muhib F; Jit M; Ghani AC
    Lancet; 2016 Jan; 387(10016):367-375. PubMed ID: 26549466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study.
    Thompson HA; Hogan AB; Walker PGT; Winskill P; Zongo I; Sagara I; Tinto H; Ouedraogo JB; Dicko A; Chandramohan D; Greenwood B; Cairns M; Ghani AC
    Lancet Glob Health; 2022 Dec; 10(12):e1782-e1792. PubMed ID: 36400084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
    Hogan AB; Winskill P; Ghani AC
    PLoS Med; 2020 Nov; 17(11):e1003377. PubMed ID: 33253211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case reduction and cost-effectiveness of the RTS,S/AS01 malaria vaccine alongside bed nets in Lilongwe, Malawi.
    Bell GJ; Loop M; Topazian HM; Hudgens M; Mvalo T; Juliano JJ; Kamthunzi P; Tegha G; Mofolo I; Hoffman I; Bailey JA; Emch M
    Vaccine; 2020 May; 38(25):4079-4087. PubMed ID: 32362527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa.
    Galactionova K; Tediosi F; Camponovo F; Smith TA; Gething PW; Penny MA
    Vaccine; 2017 Jan; 35(1):53-60. PubMed ID: 27890400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.
    Schmit N; Topazian HM; Natama HM; Bellamy D; Traoré O; Somé MA; Rouamba T; Tahita MC; Bonko MDA; Sourabié A; Sorgho H; Stockdale L; Provstgaard-Morys S; Aboagye J; Woods D; Rapi K; Datoo MS; Lopez FR; Charles GD; McCain K; Ouedraogo JB; Hamaluba M; Olotu A; Dicko A; Tinto H; Hill AVS; Ewer KJ; Ghani AC; Winskill P
    Lancet Infect Dis; 2024 May; 24(5):465-475. PubMed ID: 38342107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage.
    Unwin HJT; Mwandigha L; Winskill P; Ghani AC; Hogan AB
    Malar J; 2021 Nov; 20(1):438. PubMed ID: 34789253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.
    RTS,S Clinical Trials Partnership
    Lancet; 2015 Jul; 386(9988):31-45. PubMed ID: 25913272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa.
    Winskill P; Walker PG; Griffin JT; Ghani AC
    BMJ Glob Health; 2017; 2(1):e000090. PubMed ID: 28588994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal vaccination with RTS,S/AS01
    Dicko A; Ouedraogo JB; Zongo I; Sagara I; Cairns M; Yerbanga RS; Issiaka D; Zoungrana C; Sidibe Y; Tapily A; Nikièma F; Sompougdou F; Sanogo K; Kaya M; Yalcouye H; Dicko OM; Diarra M; Diarra K; Thera I; Haro A; Sienou AA; Traore S; Mahamar A; Dolo A; Kuepfer I; Snell P; Grant J; Webster J; Milligan P; Lee C; Ockenhouse C; Ofori-Anyinam O; Tinto H; Djimde A; Chandramohan D; Greenwood B
    Lancet Infect Dis; 2024 Jan; 24(1):75-86. PubMed ID: 37625434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01
    Cairns M; Barry A; Zongo I; Sagara I; Yerbanga SR; Diarra M; Zoungrana C; Issiaka D; Sienou AA; Tapily A; Sanogo K; Kaya M; Traore S; Diarra K; Yalcouye H; Sidibe Y; Haro A; Thera I; Snell P; Grant J; Tinto H; Milligan P; Chandramohan D; Greenwood B; Dicko A; Ouedraogo JB
    BMC Med; 2022 Oct; 20(1):352. PubMed ID: 36203149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial.
    Otieno L; Oneko M; Otieno W; Abuodha J; Owino E; Odero C; Mendoza YG; Andagalu B; Awino N; Ivinson K; Heerwegh D; Otsyula N; Oziemkowska M; Usuf EA; Otieno A; Otieno K; Leboulleux D; Leach A; Oyieko J; Slutsker L; Lievens M; Cowden J; Lapierre D; Kariuki S; Ogutu B; Vekemans J; Hamel MJ
    Lancet Infect Dis; 2016 Oct; 16(10):1134-1144. PubMed ID: 27394191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01
    Chandramohan D; Dicko A; Zongo I; Sagara I; Cairns M; Kuepfer I; Diarra M; Tapily A; Issiaka D; Sanogo K; Mahamar A; Sompougdou F; Yerbanga S; Thera I; Milligan P; Tinto H; Ofori-Anyinam O; Ouedraogo JB; Greenwood B
    BMJ Open; 2020 Sep; 10(9):e035433. PubMed ID: 32933955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perennial malaria chemoprevention with and without malaria vaccination to reduce malaria burden in young children: a modelling analysis.
    Runge M; Stahlfeld A; Ambrose M; Toh KB; Rahman S; Omoniwa OF; Bever CA; Oresanya O; Uhomoibhi P; Galatas B; Tibenderana JK; Gerardin J
    Malar J; 2023 Apr; 22(1):133. PubMed ID: 37095480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report.
    Merle CS;
    Malar J; 2023 Aug; 22(1):242. PubMed ID: 37612716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.
    RTS,S Clinical Trials Partnership
    PLoS Med; 2014 Jul; 11(7):e1001685. PubMed ID: 25072396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness and public health impact of RTS,S/AS01
    Ndeketa L; Mategula D; Terlouw DJ; Bar-Zeev N; Sauboin CJ; Biernaux S
    Wellcome Open Res; 2020; 5():260. PubMed ID: 34632084
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of insecticide-treated bed nets on the incidence and prevalence of malaria in children in an area of unstable seasonal transmission in western Myanmar.
    Smithuis FM; Kyaw MK; Phe UO; van der Broek I; Katterman N; Rogers C; Almeida P; Kager PA; Stepniewska K; Lubell Y; Simpson JA; White NJ
    Malar J; 2013 Oct; 12():363. PubMed ID: 24119916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.